Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Cho

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Japanese Circulation Journal|December 8, 2000
Successful management of intractable coronary spasm with a coronary stentM H Jeong, J C Park, J Y Rhew, et al.
Transplantation Proceedings|June 7, 2017
Effect of Changes in Body Mass Index on Cardiovascular Outcomes in Kidney Transplant RecipientsK Y Kim, J-H Cho, H-Y Jung, et al.
Anatomia, Histologia, Embryologia|November 21, 2017
The distribution of calbindinD-28k and parvalbumin immunoreactive neurons in the somatosensory area of the pigeon palliumJ H Ahn, J H Park, S Y Choi, et al.
Archives of Virology|September 25, 2003
Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000Y M Jee, D-S Cheon, K Kim, et al.
Transplantation Proceedings|June 4, 2013
Risk factors for recurrent urinary tract infection in kidney transplant recipientsJ-H Lim, J-H Cho, J-H Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1998
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1J H Cho, D L Nicolae, L H Gold, et al.
Nature|June 1, 2001
A frameshift mutation in NOD2 associated with susceptibility to Crohn's diseaseY Ogura, D K Bonen, N Inohara, et al.
Transplantation Proceedings|May 8, 2018
Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney TransplantationK H Lee, D I Won, J-M Yook, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
Genes and Immunity|July 25, 2008
MAST3: a novel IBD risk factor that modulates TLR4 signalingC Labbé, P Goyette, C Lefebvre, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Japanese Circulation Journal|December 8, 2000
Successful management of intractable coronary spasm with a coronary stentM H Jeong, J C Park, J Y Rhew, et al.
Transplantation Proceedings|June 7, 2017
Effect of Changes in Body Mass Index on Cardiovascular Outcomes in Kidney Transplant RecipientsK Y Kim, J-H Cho, H-Y Jung, et al.
Anatomia, Histologia, Embryologia|November 21, 2017
The distribution of calbindinD-28k and parvalbumin immunoreactive neurons in the somatosensory area of the pigeon palliumJ H Ahn, J H Park, S Y Choi, et al.
Archives of Virology|September 25, 2003
Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000Y M Jee, D-S Cheon, K Kim, et al.
Transplantation Proceedings|June 4, 2013
Risk factors for recurrent urinary tract infection in kidney transplant recipientsJ-H Lim, J-H Cho, J-H Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1998
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1J H Cho, D L Nicolae, L H Gold, et al.
Nature|June 1, 2001
A frameshift mutation in NOD2 associated with susceptibility to Crohn's diseaseY Ogura, D K Bonen, N Inohara, et al.
Transplantation Proceedings|May 8, 2018
Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney TransplantationK H Lee, D I Won, J-M Yook, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
Genes and Immunity|July 25, 2008
MAST3: a novel IBD risk factor that modulates TLR4 signalingC Labbé, P Goyette, C Lefebvre, et al.
Pageof 26